(R)-(+)-2-异丁基丁二酸2-甲基酯 | 130165-76-3

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: (R)-(+)-2-异丁基丁二酸2-甲基酯
• 中文别名: (R)-2-异丁基琥珀酸-1-甲酯
• 英文名称: (R)-2-isobutylsuccinic acid 1-methyl ester
• 英文别名: (R)-3-(methoxycarbonyl)-5-methylhexanoic acid；(R)-3-methoxycarbonyl-5-methylcaproic acid；(R)-2-isobutylsuccinic acid-1-methyl ester；(3R)-3-methoxycarbonyl-5-methylhexanoic acid
• CAS: 130165-76-3
• 化学式: C₉H₁₆O₄
• 分子量: 188.224
• InChiKey: AJNNFMRCMKGYHA-SSDOTTSWSA-N

物化性质

• 沸点：
  243.23°C (rough estimate)
• 密度：
  1.0725 (rough estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  13
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 安全说明：
  S24/25
• 海关编码：
  2918990090
• 储存条件：
  Refrigerator (＋4°C)

SDS

Name:	(R)-2-Isobutylsuccinic Acid-1-Methyl Ester 95% (98% E.E.) Material Safety Data Sheet
Synonym:	(R)-3-Methoxycarbonyl-5-Methylhexanoic Acid
CAS:	130165-76-3

Section 1 - Chemical Product MSDS Name:(R)-2-Isobutylsuccinic Acid-1-Methyl Ester 95% (98% E.E.) Material Safety Data Sheet
Synonym:(R)-3-Methoxycarbonyl-5-Methylhexanoic Acid

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
130165-76-3	(R)-2-Isobutylsuccinic Acid-1-Methyl E	95%	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a dry area. Keep refrigerated. (Store below 4C/39F.)

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 130165-76-3: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Viscous liquid
Color: yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H16O4
Molecular Weight: 188.22

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not currently available.
Conditions to Avoid:
Incompatible materials, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 130165-76-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(R)-2-Isobutylsuccinic Acid-1-Methyl Ester - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 130165-76-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 130165-76-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 130165-76-3 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  正丙胺 、 (R)-(+)-2-异丁基丁二酸2-甲基酯 在 2-(7-aza-1H-benzotriazol-1-yl)-1,1,3,3-tetratetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 以 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 0.25h， 以83%的产率得到(2R)-4-methyl-2-propylcarbamoylmethyl-pentanoic Acid Methyl Ester
  参考文献：
  名称：

  Tetrazolylpropionamides as inhibitors of Abeta protein production

  摘要：

  这项发明涉及新型四唑基丙酰胺，其中酰胺基团包括氨基环庚酮，以及与之相关的结构，化学式（I）： 1 或其药学上可接受的盐或前药形式，它们的药物组合物和使用方法。这些新型化合物抑制淀粉样前体蛋白的加工，更具体地说，抑制Aβ-肽的产生，从而预防和治疗与Aβ-肽产生相关的神经病理学。更具体地，本发明涉及与β-淀粉样蛋白产生相关的神经系统疾病的治疗，如阿尔茨海默病。

  公开号：

  US20040082568A1
• 作为产物：
  描述：

  (E)-2-(1-isobutylidene)succinic acid 1-methyl ester 在 [Rh((R,R)-iPr-JDayPhos)(MeOH)₂]BF₄ 、 氢气 作用下， 以 甲醇 为溶剂， 22.0 ℃ 、300.01 kPa 条件下， 反应 0.5h， 以99%的产率得到
  参考文献：
  名称：

  1,1'-二茂铁基核心的P-Stereogenic二膦酸酯模块：''JDayPhos''系列及其在铑（I）催化加氢中的应用

  摘要：

  开发了一种新型的基于二茂铁的P-立体异构二膦配体系列JDayPhos，该化合物的一些成员的铑（I）配合物表现出出色的对映选择性（高达> 99％ee），并且在β-未取代或-β的不对称氢化中表现出高活性。取代的衣康酸酯和α-亚甲基-γ-氧代羧酸酯。

  DOI：

  10.1002/adsc.201800255

文献信息

• A Novel Chiral Ferrocenyl Phosphine Ligand from Sugar:  Applications in Rh-Catalyzed Asymmetric Hydrogenation Reactions
  作者：Duan Liu、Wenge Li、Xumu Zhang

  DOI：10.1021/ol0269998

  日期：2002.12.1

  [structure: see text] A new chiral ferrocenyl diphosphine ligand 3 was synthesized from readily available D-mannitol. Rh-complex with this ligand showed high enantioselectivity and reactivity in the asymmetric hydrogenation of dehydroamino acid derivatives and itaconic acid derivatives. Up to over 99% ee and 10 000 TON were achieved with this catalytic system.

  [结构：见正文]从容易获得的D-甘露糖醇合成了新的手性二茂铁基二膦配体3。具有这种配体的Rh-络合物在脱氢氨基酸衍生物和衣康酸衍生物的不对称氢化中显示出高的对映选择性和反应性。使用该催化系统可实现高达99％的ee和10000吨。
• NOVEL BISPHOSPHINE LIGAND
  申请人：WATANABE Michimasa

  公开号：US20080242534A1

  公开（公告）日：2008-10-02

  A compound represented by the following general formula (I): [wherein R 1 represents hydrogen atom, or an alkyl group, R 2 represents a hydroxyalkyl group, or a triarylmethyloxyalkyl group, or R 1 and R 2 combine together to represent —C(R 3 )(R 4 )— (R 3 and R 4 represent hydrogen atom, an alkyl group, or hydroxyl group, or R 3 and R 4 may combine together to represent oxo group), or —C(R 5 )(R 6 )—O—C(R 7 )(R 8 )— (R 5 to R 8 represent hydrogen atom, an alkyl group, or hydroxyl group, or R 5 and R 6 may combine together to represent oxo group, and R 7 and R 8 may combine together to represent oxo group); Ar 1 to Ar 4 independently represent an aryl group (the aryl group may have 1 to 5 of the same or different substituents), *1 to *4 indicate asymmetric carbons, and configurations are cis between *1 and *2, cis between *3 and *4, and trans between *2 and *3]. An optically active phosphine ligand which can be easily synthesized and gives a transition metal complex showing superior asymmetric catalyst activity is provided.

  提供了一个由以下一般式（I）表示的化合物：【其中R1代表氢原子，或烷基团，R2代表羟基烷基团，或三芳基甲氧基烷基团，或R1和R2结合在一起表示—C(R3)(R4)—（R3和R4代表氢原子，烷基团，或羟基，或R3和R4可以结合在一起表示酮基），或—C(R5)(R6)—O—C(R7)(R8)—（R5到R8代表氢原子，烷基团，或羟基，或R5和R6可以结合在一起表示酮基，R7和R8可以结合在一起表示酮基）；Ar1到Ar4独立地代表芳基（芳基可能具有1到5个相同或不同的取代基），*1到*4表示不对称碳，配置在*1和*2之间为顺式，*3和*4之间为顺式，*2和*3之间为反式】。提供了一种可以轻松合成并给出显示出优越不对称催化剂活性的过渡金属配合物的光学活性膦配体。
• Novel method of treatment of inflammatory skin conditions
  申请人：Chandler Rupert Stephen

  公开号：US20070049518A1

  公开（公告）日：2007-03-01

  There is provided, inter alia, a method for the treatment or prevention of an inflammatory skin condition which is characterised by colonisation with Staphylococcus aureus , comprising the topical administration of an aureolysin inhibitor.

  提供了一种治疗或预防由金黄色葡萄球菌定植引起的炎症性皮肤病的方法，包括局部施用一种金黄色葡萄球菌溶素抑制剂。
• Novel succinate compounds, compositions and methods of use and preparation
  申请人：——

  公开号：US20020115863A1

  公开（公告）日：2002-08-22

  Novel hydroxamic acid compounds are disclosed. These hydroxamates inhibit peptidyl deformylase (PDF), an enzyme present in prokaryotes. The hydroxymates are useful as antimicrobials and antibiotics. The compounds of the invention display selective inhibition of peptidyl deformylase versus other metalloproteinases such as matrix metalloproteinases (MMPs). Methods of synthesis and of use of the compounds are also disclosed.

  揭示了一种新型羟羧酸化合物。这些羟羧酸酯抑制肽变形酶（PDF），这是一种存在于原核生物中的酶。这些羟羧酸酯可用作抗微生物和抗生素。该发明的化合物表现出对肽变形酶的选择性抑制，而不影响其他金属蛋白酶如基质金属蛋白酶（MMPs）。该文还揭示了这些化合物的合成方法和使用方法。
• ORGANIC COMPOUNDS AND THEIR USES
  申请人：Brandl Trixl

  公开号：US20100204159A1

  公开（公告）日：2010-08-12

  The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.

  本申请描述了对人类疾病的治疗、预防和/或改善有用的有机化合物。